Loading...
Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients
BACKGROUND: Multiple myeloma (MM) is a complex heterogeneous disease. Various risk stratification models have been recommended including cytogenetic and FISH analysis to identify high-risk patients who may benefit from novel treatments, but such facilities are not widely available. The International...
Na minha lista:
| Udgivet i: | BBA Clin |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502697/ https://ncbi.nlm.nih.gov/pubmed/28725572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbacli.2017.05.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|